Babak J. Mehrara
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Babak J. Mehrara has a total of 23 co-authors. Here are the top co-authors by number of shared publications:
- Pierre B. Saadeh
Hansjörg Wyss Department of Plastic Surgery, New York University Langone Health, New York, New York
5 shared publications Michael T. Longaker
4 shared publicationsDouglas S. Steinbrech
3 shared publicationsGeorge K. Gittes
3 shared publicationsJason A. Spector
3 shared publicationsJoshua A. Greenwald
3 shared publications
Latest Publications
- 1 August 2002
- Published by Wolters Kluwer Health in Plastic and Reconstructive Surgery
- Vol. 110 (2) , 506-514
Adenovirus-Mediated Transmission of a Dominant Negative Transforming Growth Factor-β Receptor Inhibits In Vitro Mouse Cranial Suture Fusion
Recent studies have implicated the transforming growth factor (TGF)-β family in the regulation of pathological sporadic cranial suture fusion. In addition, these studies have shown that TGF-β is highly expressed by the dura mater underlying fusing murine cranial sutures. The purpose of the present experiments was to analyze the effects of disrupting TGF-β signaling during programmed mouse cranial suture fusion. Using recombinant DNA technology, a replication-deficient adenovirus encoding a defective TGF-β receptor (Ad.DN-TβRII) capable of blocking TGF-β biological activity was constructed. Mouse posterior frontal sutures were harvested before the initiation of suture fusion (postnatal day 25), and the dura mater underlying the suture was infected with vehicle, Ad.DN-TβRII, or control virus (Ad.LacZ; n = 10 each). Sutures were cultured for 14 or 30 days in an organ culture system and analyzed macroscopically and histologically. X-gal staining of Ad.LacZ-infected sutures 14 days after culture revealed strong staining of cells localized to the dura mater. Macroscopic analysis revealed complete sutural fusion in vehicle and Ad.LacZ-infected sutures. In contrast, Ad.DN-TBRII-infected sutures demonstrated nearly complete patency. Histological analysis confirmed our macroscopic observations with sutural fusion in 81.3 ± 10 percent and 74.5 ± 9 percent of vehicle and Ad.LacZ-infected sutures, respectively, versus 38.1 ± 12 percent (p < 0.001) in Ad.DN-TβRII-infected sutures. In addition, transfection with the Ad.DN-TβRII virus resulted in a significant attenuation of anterior-to-posterior suture fusion, with the majority of fused sections localized to anterior sections. These data strongly implicate TGF-β biological activity in the dura mater underlying the posterior frontal suture in the regulation of programmed sutural fusion. In addition, this study demonstrates the utility of adenovirus-mediated gene transfer in preventing programmed sutural fusion. (Plast. Reconstr. Surg. 110: 506, 2002.)
- 1 August 2002
- Published by Wolters Kluwer Health in Plastic and Reconstructive Surgery
- Vol. 110 (2) , 506-514
Adenovirus-Mediated Transmission of a Dominant Negative Transforming Growth Factor-β Receptor Inhibits In Vitro Mouse Cranial Suture Fusion
Recent studies have implicated the transforming growth factor (TGF)-β family in the regulation of pathological sporadic cranial suture fusion. In addition, these studies have shown that TGF-β is highly expressed by the dura mater underlying fusing murine cranial sutures. The purpose of the present experiments was to analyze the effects of disrupting TGF-β signaling during programmed mouse cranial suture fusion. Using recombinant DNA technology, a replication-deficient adenovirus encoding a defective TGF-β receptor (Ad.DN-TβRII) capable of blocking TGF-β biological activity was constructed. Mouse posterior frontal sutures were harvested before the initiation of suture fusion (postnatal day 25), and the dura mater underlying the suture was infected with vehicle, Ad.DN-TβRII, or control virus (Ad.LacZ; n = 10 each). Sutures were cultured for 14 or 30 days in an organ culture system and analyzed macroscopically and histologically. X-gal staining of Ad.LacZ-infected sutures 14 days after culture revealed strong staining of cells localized to the dura mater. Macroscopic analysis revealed complete sutural fusion in vehicle and Ad.LacZ-infected sutures. In contrast, Ad.DN-TBRII-infected sutures demonstrated nearly complete patency. Histological analysis confirmed our macroscopic observations with sutural fusion in 81.3 ± 10 percent and 74.5 ± 9 percent of vehicle and Ad.LacZ-infected sutures, respectively, versus 38.1 ± 12 percent (p < 0.001) in Ad.DN-TβRII-infected sutures. In addition, transfection with the Ad.DN-TβRII virus resulted in a significant attenuation of anterior-to-posterior suture fusion, with the majority of fused sections localized to anterior sections. These data strongly implicate TGF-β biological activity in the dura mater underlying the posterior frontal suture in the regulation of programmed sutural fusion. In addition, this study demonstrates the utility of adenovirus-mediated gene transfer in preventing programmed sutural fusion. (Plast. Reconstr. Surg. 110: 506, 2002.)
- 1 September 2000
- Published by Wolters Kluwer Health in Plastic and Reconstructive Surgery
- Vol. 106 (3) , 639
Immature versus Mature Dura Mater: II. Differential Expression of Genes Important to Calvarial Reossification
- 1 September 2000
- Published by Wolters Kluwer Health in Plastic and Reconstructive Surgery
- Vol. 106 (3) , 639
Immature versus Mature Dura Mater: II. Differential Expression of Genes Important to Calvarial Reossification
- 1 September 2000
- Published by Wolters Kluwer Health in Plastic and Reconstructive Surgery
- Vol. 106 (4) , 862-867
A Molecular Analysis of the Isolated Rat Posterior Frontal and Sagittal Sutures: Differences in Gene Expression
- 1 September 2000
- Published by Wolters Kluwer Health in Plastic and Reconstructive Surgery
- Vol. 106 (4) , 862-867
A Molecular Analysis of the Isolated Rat Posterior Frontal and Sagittal Sutures: Differences in Gene Expression
- 1 April 2000
- Published by Wolters Kluwer Health in Plastic and Reconstructive Surgery
- Vol. 105 (4) , 1382-1392
Biomolecular Mechanisms of Calvarial Bone Induction: Immature versus Mature Dura Mater
- 1 April 2000
- Published by Wolters Kluwer Health in Plastic and Reconstructive Surgery
- Vol. 105 (4) , 1382-1392
Biomolecular Mechanisms of Calvarial Bone Induction: Immature versus Mature Dura Mater
- 1 September 1999
- Published by Wolters Kluwer Health in Plastic and Reconstructive Surgery
- Vol. 104 (4) , 1003-1013
Regional Differentiation of Rat Cranial Suture-Derived Dural Cells Is Dependent on Association with Fusing and Patent Cranial Sutures
A significant body of literature supports a role for the dura mater underlying cranial sutures in the regulation of sutural fate. These studies have implicated regional differentiation of the dura mater based on association with fusing and patent rat cranial sutures. The purpose of these experiments was to isolate and characterize dural cells associated with fusing (posterior frontal) and patent (sagittal) rat cranial sutures. Six-day-old rats were killed, and the dura mater underlying the posterior frontal and sagittal sutures was harvested. Dural cells were briefly trypsinized and allowed to reach confluence. Two litters (10 animals per litter) were used for each set of experiments. Cells were harvested after the first and fifth passages for analysis of vimentin and desmoplakin expression (characteristic of human meningeal cells), cellular proliferation, density at confluence (a measure of cellular contact inhibition), and alkaline phosphatase production. In addition, bone nodule formation and collagen I production were analyzed in first passage cells. The results indicate that suture-derived dural cells can be established and that these cells coexpress vimentin and desmoplakin. In addition, it is demonstrated that first-passage sagittal suture-derived dural cells proliferate significantly faster and have decreased cellular contact inhibition than posterior frontal suture-derived cells (p < 0.01). Finally, it is shown that suture-derived dural cells have osteoblast-like properties, including alkaline phosphatase production, collagen I expression, and bone nodule formation in vitro. The possible mechanisms by which regional differentiation of suture-derived dural cells occur are discussed. (Plast. Reconstr. Surg. 104: 1003, 1999.)
- 1 September 1999
- Published by Wolters Kluwer Health in Plastic and Reconstructive Surgery
- Vol. 104 (4) , 1003-1013
Regional Differentiation of Rat Cranial Suture-Derived Dural Cells Is Dependent on Association with Fusing and Patent Cranial Sutures
A significant body of literature supports a role for the dura mater underlying cranial sutures in the regulation of sutural fate. These studies have implicated regional differentiation of the dura mater based on association with fusing and patent rat cranial sutures. The purpose of these experiments was to isolate and characterize dural cells associated with fusing (posterior frontal) and patent (sagittal) rat cranial sutures. Six-day-old rats were killed, and the dura mater underlying the posterior frontal and sagittal sutures was harvested. Dural cells were briefly trypsinized and allowed to reach confluence. Two litters (10 animals per litter) were used for each set of experiments. Cells were harvested after the first and fifth passages for analysis of vimentin and desmoplakin expression (characteristic of human meningeal cells), cellular proliferation, density at confluence (a measure of cellular contact inhibition), and alkaline phosphatase production. In addition, bone nodule formation and collagen I production were analyzed in first passage cells. The results indicate that suture-derived dural cells can be established and that these cells coexpress vimentin and desmoplakin. In addition, it is demonstrated that first-passage sagittal suture-derived dural cells proliferate significantly faster and have decreased cellular contact inhibition than posterior frontal suture-derived cells (p < 0.01). Finally, it is shown that suture-derived dural cells have osteoblast-like properties, including alkaline phosphatase production, collagen I expression, and bone nodule formation in vitro. The possible mechanisms by which regional differentiation of suture-derived dural cells occur are discussed. (Plast. Reconstr. Surg. 104: 1003, 1999.)
- 1 May 1999
- Published by Wolters Kluwer Health in Annals of Plastic Surgery
- Vol. 42 (5) , 496-501
Analysis of TGF-β Production by Fusing and Nonfusing Mouse Cranial Sutures In Vitro
The role of transforming growth factor beta (TGF-beta) in the regulation of cranial suture fusion has been studied by various qualitative techniques such as in situ hybridization and immunohistochemistry. Although the relative expression of TGF-beta isoforms has been assessed in these studies, increased expression of TGF-beta has not been demonstrated in a quantitative fashion. Therefore, the purpose of this study was to quantify TGF-beta production by fusing (posterofrontal [PF]) and nonfusing (sagittal) mouse sutures using two different quantitative TGF-beta assays. The PF and sagittal sutures of 25-day-old mice were harvested and cultured separately in vitro. Culture media conditioned for 48 hours were collected after 3, 6, 9, 12, 15, 18, 21, 24, 27, and 30 days of culture, and total TGF-beta production was assessed using a TGF-beta bioassay. For a quantitative TGF-beta1 immunoassay, media conditioned for 48 hours were collected after 3, 5, 7, 9, 14, 22, and 28 days of culture. The TGF-beta bioassay revealed large amounts of total TGF-beta activity in both PF and sagittal sutures during the first week of culture, with decreasing amounts thereafter. Absolute TGF-beta activity in conditioned media collected from PF sutures at several early time points was higher than those obtained from sagittal sutures; however, these differences were not statistically significant. The results of the TGF-beta1 immunoassay (enzyme-linked immunosorbent assay) were similar to the bioassay in that the highest TGF-beta1 levels were noted during the first week of culture period and decreased thereafter. Analysis of variance of these samples, however, revealed significantly more TGF-beta1 protein in samples collected from the PF suture compared with the sagittal suture on days 3 and 5 of culture (p < 0.05). TGF-beta1 levels in the conditioned media obtained from PF sutures remained elevated compared with the sagittal suture on days 7 and 9; however, these differences were not statistically significant. Increased production of TGF-beta in the conditioned media of fusing PF sutures is the first such quantitative demonstration of growth factor upregulation during suture fusion and supports the hypothesis that TGF-beta expression may be important in cranial suture fusion.
- 1 May 1999
- Published by Wolters Kluwer Health in Annals of Plastic Surgery
- Vol. 42 (5) , 496-501
Analysis of TGF-β Production by Fusing and Nonfusing Mouse Cranial Sutures In Vitro
The role of transforming growth factor beta (TGF-beta) in the regulation of cranial suture fusion has been studied by various qualitative techniques such as in situ hybridization and immunohistochemistry. Although the relative expression of TGF-beta isoforms has been assessed in these studies, increased expression of TGF-beta has not been demonstrated in a quantitative fashion. Therefore, the purpose of this study was to quantify TGF-beta production by fusing (posterofrontal [PF]) and nonfusing (sagittal) mouse sutures using two different quantitative TGF-beta assays. The PF and sagittal sutures of 25-day-old mice were harvested and cultured separately in vitro. Culture media conditioned for 48 hours were collected after 3, 6, 9, 12, 15, 18, 21, 24, 27, and 30 days of culture, and total TGF-beta production was assessed using a TGF-beta bioassay. For a quantitative TGF-beta1 immunoassay, media conditioned for 48 hours were collected after 3, 5, 7, 9, 14, 22, and 28 days of culture. The TGF-beta bioassay revealed large amounts of total TGF-beta activity in both PF and sagittal sutures during the first week of culture, with decreasing amounts thereafter. Absolute TGF-beta activity in conditioned media collected from PF sutures at several early time points was higher than those obtained from sagittal sutures; however, these differences were not statistically significant. The results of the TGF-beta1 immunoassay (enzyme-linked immunosorbent assay) were similar to the bioassay in that the highest TGF-beta1 levels were noted during the first week of culture period and decreased thereafter. Analysis of variance of these samples, however, revealed significantly more TGF-beta1 protein in samples collected from the PF suture compared with the sagittal suture on days 3 and 5 of culture (p < 0.05). TGF-beta1 levels in the conditioned media obtained from PF sutures remained elevated compared with the sagittal suture on days 7 and 9; however, these differences were not statistically significant. Increased production of TGF-beta in the conditioned media of fusing PF sutures is the first such quantitative demonstration of growth factor upregulation during suture fusion and supports the hypothesis that TGF-beta expression may be important in cranial suture fusion.